Daniel M. Cohen

Podiatric Medicine

1500 Horizon Drive
Suite 106
Chalfont, PA 18914

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

AAV-delivered PPT1 provides long-term neurological benefits in CLN1 mice and achieves therapeutic levels in sheep brain.

AAV-delivered PPT1 provides long-term neurological benefits in CLN1 mice and achieves therapeutic levels in sheep brain.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 04, 2025

IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.

IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.

Journal: Nature medicine

Published: January 23, 2020

Showing 1-2 of 2

Last Updated: 09/26/2026